Bridge Biotherapeutics, Inc. (KOSDAQ: 288330)
South Korea
· Delayed Price · Currency is KRW
3,960.00
+325.00 (8.94%)
Sep 11, 2024, 3:00 PM KST
Bridge Biotherapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 182,554 | 73,111 | 230,799 | 279,845 | 279,086 | 317,282 | |
Market Cap Growth | -57.47% | -68.32% | -17.53% | 0.27% | -12.04% | - | |
Enterprise Value | 179,228 | 50,708 | 172,628 | 231,285 | 216,852 | 319,939 | |
Last Close Price | 3985.00 | 2386.14 | 8425.95 | 10314.52 | 10568.76 | 13897.97 | |
PE Ratio | - | -1.39 | -4.81 | -9.20 | -12.56 | 121.59 | |
PS Ratio | -332083333.33 | 731.11 | 76.33 | 145.44 | 44.02 | 5.44 | |
PB Ratio | 9.88 | 3.71 | 4.45 | 6.50 | 4.71 | 4.23 | |
P/FCF Ratio | -1.64 | -2.28 | -5.68 | -13.14 | -21.28 | -38.74 | |
P/OCF Ratio | -1.65 | -2.30 | -5.74 | -13.25 | -21.41 | -41.22 | |
EV/Sales Ratio | -105705175.01 | 507.08 | 57.09 | 120.20 | 34.20 | 5.49 | |
EV/EBITDA Ratio | -1.24 | -1.30 | -4.07 | -8.89 | -11.28 | 299.40 | |
EV/EBIT Ratio | -1.18 | -1.26 | -3.97 | -8.76 | -11.08 | 518.38 | |
EV/FCF Ratio | -6.52 | -1.58 | -4.25 | -10.86 | -16.53 | -39.06 | |
Debt / Equity Ratio | 0.25 | 0.18 | 0.06 | 0.01 | 0.01 | 0.00 | |
Debt / EBITDA Ratio | - | - | - | - | - | 0.15 | |
Debt / FCF Ratio | -0.11 | -0.11 | -0.07 | -0.01 | -0.03 | -0.02 | |
Asset Turnover | - | 0.00 | 0.06 | 0.03 | 0.09 | 1.28 | |
Quick Ratio | 1.51 | 2.01 | 6.97 | 12.23 | 56.55 | 15.34 | |
Current Ratio | 1.57 | 2.09 | 7.33 | 12.49 | 57.14 | 16.72 | |
Return on Equity (ROE) | -143.32% | -118.61% | -87.87% | -51.39% | -28.65% | 6.52% | |
Return on Assets (ROA) | -58.54% | -53.58% | -50.30% | -29.95% | -17.08% | 0.84% | |
Return on Capital (ROIC) | -67.36% | -64.55% | -55.40% | -32.06% | -18.15% | 1.50% | |
Earnings Yield | -31.21% | -57.89% | -18.07% | -9.39% | -6.89% | 0.42% | |
FCF Yield | -15.06% | -43.90% | -17.60% | -7.61% | -4.70% | -2.58% | |
Buyback Yield / Dilution | -21.53% | -3.58% | -1.56% | -2.53% | -96.53% | -64.86% | |
Total Shareholder Return | -21.53% | -3.58% | -1.56% | -2.53% | -96.53% | -64.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.